60% of Advanced Ceramics Sales Concentrated in Power and

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2022
19
60% of Advanced Ceramics Sales Concentrated in Power and Metallurgy, finds Fact.MR study

Rockville, MD, Feb. 13, 2019 (GLOBE NEWSWIRE) -- Advanced ceramics continue to spark a notable interest in the high-performance engineering applications, with a foreseen phenomenal growth potential in defense and aerospace. Advanced ceramics sales surpassed 40,500 MT in 2018 , according to a recent Fact.MR study. Advanced ceramics have already sought extensive demand in electronics & power, and industrial & metallurgical applications, collectively accounting for approximately 60% of overall sales in 2018.

As the shift toward low-carbon economy becomes pervasive, key players in the advanced ceramics market are eyeing potential gains from the piezoelectric space. Government and private equity investments in the energy-harvesting technologies have significantly advocated developments in piezoelectric sensors and transducers, in turn alluding bright prospects for advanced ceramics in the electronics and power applications.

Advanced ceramics consumption in industrial and metallurgical applications can be attributed to remarkable advances in alloy and metal manufacturing, which have paved ground for modern-day revolution in material technologies. The rise of smart factories is another demand determinant of advanced ceramics, as technologies such as artificial intelligence, IoT, robotics and automation gain momentous palpability.

Request For Sample Report- https://www.factmr.com/connectus/sample?flag=...ep_id=2993

Monolithic Ceramics at the Forefront, Despite Remarkable Sales Prospects of Ceramic Coatings and CMCs

Monolithic ceramics prevail as the preferred class of advanced ceramics, with significant evolution in their development patterns. Enhanced performance attributes of monolithic ceramics, including stability, flexibility, toughness, and resilience, continue to underpin their supremacy over other advanced ceramic variants. According to the study, despite remarkable sales prospects foreseen for the ceramic coatings and ceramic matrix composites (CMCs), monolithic ceramics will continue to spearhead the advanced ceramics market, with over 80% of overall volume sales.

Ceramic coatings and CMC sales are likely to record a relatively faster growth in sales, as these have been deemed to hold higher specific strength over larger temperature range, along with greater damage tolerance, than monolithic ceramics. However, the affordable nature of monolithic ceramics compared to other variants, and higher fracture toughness, will continue to underpin their reign in the advanced ceramics market.

Browse Full Report on Advanced Ceramics Market with in-depth TOC- https://www.factmr.com/report/2993/advanced-ceramics-market

Alumina ceramics will continue to clasp a significant share of the advanced ceramics market, backed by the fact that alumina-based composites are integral requirements for fabrication of monolithic specimens. Popularity of alumina ceramics as a desirable material is undergird by its ability to form convolute shapes, while facilitating transparency and precision at both large and small dimensions, at reduced cost.

Silicon nitride-based composites have also been a vital component of monolithic ceramics, which in turn has added to their popularity in the advanced ceramics market. Currently, alumina ceramics and silicon nitride collectively account for nearly 6 in 10 MT of advanced ceramics sold worldwide.

APEJ Reigns Supreme in Advanced Ceramics Consumption

Sovereignty of Asia-Pacific excluding Japan in the advanced ceramics market shows no signs of abating, underpinned by key aspects that include competitive manufacturing prices, significant economic growth, and rapid momentum of end-use verticals in the region. With the aim of region’s developing economics such as China and India to become global leaders in automobile manufacturing in terms of cutting edge vehicle electrification technologies, demand for advanced ceramics will continue to remain robust in the region. Apart from demand for electroceramics, resurgent growth in the residential construction, coupled with various infrastructure development projects, is a significant growth determinant for the advanced ceramics market in APEJ.

Have Any Query? Ask Our Industry Expert- https://www.factmr.com/connectus/sample?flag=...ep_id=2993

Recent developments in the ceramic science have meant that costly fabrication techniques are near redundancy. Producing robust transparent ceramic items, while retaining the translucency, is gaining momentous focus among key players in the advanced ceramics market, abreast efforts to address structural heterogeneities. This will further pave ground for developments in advanced ceramics in the upcoming years.

This report of Fact.MR also offers a detailed forecast of the advanced ceramics market for the period, 2018 to 2027. The advanced ceramics market is envisaged to record an impressive CAGR of nearly 7% through 2027 .

To Buy Advanced Ceramics Market Report, Check- https://www.factmr.com/checkout/2993/S

About Fact.MR

Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

Contact Us

Rohit Bhisey Fact.MR 11140 Rockville Pike Suite 400 Rockville, MD 20852 United States Email: sales@factmr.com

Web: https://www.factmr.com/

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Evotec’s $2.9M Grant Advances Drug Safety Tech

Updated Category News Views 87

Revitalizing Drug Development with Human Stem Cells Evotec's latest win—a crisp $2.9 million grant from the Gates Foundation—is like a shot of adrenaline for drug safety innovation. This isn't just another drop in the bucket; it's a solid boost toward improving how we screen potential drugs for fetal risks before they're tossed into the costly whirlpool of clinical...

Continue Reading
Investors Gear Up for Lennar Class Action Lawsuit

Updated Category News Views 399

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 448

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Segway Powersports Dominates Baja 1000 with Class 2 Sweep

Updated Category News Views 72

Catching the eye of any betting man, Segway Powersports has turned its maiden outing at the relentless SCORE Baja 1000 into a rousing victory. Their arrival on this unforgiving stage with a one-two in Class 2 isn't just a lucky roll—you don't chance upon podium sweeps in such gritty contests. Dissecting the Drive: Commitment and Coordination Unfolding across Baja's...

Continue Reading
Pollo AI Unveils York AI: Automating Social Growth

Updated Category News Views 0

York AI Debuts as the New Kid on the Block Amid the hustle and bustle of a tech-savvy Singapore, Pollo AI’s latest offering, York AI, sashays onto the scene with the promise of putting social media growth on cruise control. We're talking about a digital sidekick that seems to know your online persona better than you do. It’s tailored for everyone from the small-time...

Continue Reading
Ascletis' Preclinical Successes: Future of Obesity Treatment

Updated Category News Views 14

Pharma Giants Eyeing a New Potential Well, it seems the world of pharma is buzzing with Ascletis’ latest developments in the obesity treatment arena. They’ve just showcased some intriguing preclinical data at ObesityWeek® 2026. The standout? A cocktail of advancements that might just put a dent in the obesity epidemic if further studies pan out. ASC30_48: A Daily...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 412

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
Fapon's MEDICA 2026 Bid: Game-Changer or Same Old?

Updated Category News Views 89

Fapon's Ambitious Pitch at MEDICA: A Real Deal? MEDICA 2026 sees Fapon stepping up, laden with flashy promises and hardened expertise. Set up in Düsseldorf, these folks are pushing their Local Manufacturing Solutions harder than a door-to-door vacuum seller. The main pitch? Bolstering local IVD production with their comprehensive tech transfer services. How many outfits...

Continue Reading
Local Voices to Shape Mekong's Story in New Alliance

Updated Category News Views 284

Unpacking the New Storytelling Strategy Right off the bat, let's make it clear—this isn't just another run-of-the-mill environmental project announcement. When the National Geographic Society teams up with ThaiBev to empower Southeast Asian storytellers, they're not just waving around the usual conservation banner. Instead, they're betting on local voices to lead the...

Continue Reading
Akeso's Gumokimab Wins NMPA Approval for AS Treatment

Updated Category News Views 115

Gumokimab Approved: A New Dawn in AS Treatment Yeah, the biotech world shifts gears today as Akeso's gumokimab received the green light from China's National Medical Products Administration (NMPA). This approval for treating ankylosing spondylitis, or AS, isn't just another checkbox for Akeso; it's a game-changer in tackling this chronic inflammatory disease. Why should...

Continue Reading

Top 5 Most Recently Viewed Articles

O-I Glass Announces Participation in Citi’s 2025 Conference

Updated Category News Views 208

O-I Glass Participation in the 2025 Basic Materials Conference PERRYSBURG, Ohio — O-I Glass, Inc., known for its commitment to creating exceptional glass products, is set to participate in the upcoming Citi’s 2025 Basic Materials Conference. This significant event will take place on a Wednesday in December, and features notable presentations from O-I's leadership....

Continue Reading
Osmium Partners Proposes Strategic Plan for Articore Growth

Updated Category News Views 104

Osmium Partners Proposes a Four-Step Plan for Articore Osmium Partners has recently made headlines with their proposal for Articore, aiming to elevate shareholder value through a methodical four-step approach. This initiative is driven by Osmium's belief that Articore's current management strategy lacks direction and has resulted in missed opportunities for growth and...

Continue Reading
Amplify Energy Set to Shine at EnerCom Denver Conference 2025

Updated Category News Views 135

Amplify Energy’s Participation in EnerCom Denver Conference Amplify Energy Corp. is gearing up to participate in the renowned annual EnerCom Denver Conference in 2025. This event, known for bringing together leading experts and investors in the energy sector, offers Amplify a prime platform to showcase its strategic initiatives and growth potential. Focus on Investor...

Continue Reading
Safe Life Expands CPR Training and AED Services through Acquisition

Updated Category News Views 197

Safe Life Strengthens National Coverage for Life-Saving Training Safe Life has made a significant move by acquiring HeartCert, a company known for its specialization in automated external defibrillators (AEDs) and CPR training. This acquisition allows Safe Life to broaden its reach into the Midwest, enhancing its commitment to providing life-saving training and equipment...

Continue Reading
Express Scripts Challenges FTC's Drug Pricing Conclusions

Updated Category News Views 106

Express Scripts Files Lawsuit Against the FTC Express Scripts, a major player in the pharmacy benefit manager sector, has recently taken legal action against the U.S. Federal Trade Commission (FTC). This lawsuit stems from a report that criticizes the role of pharmacy benefit managers in the pricing of medications. Express Scripts contends that the report's conclusions...

Continue Reading